Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darden

Showing results (641-650 of 661) with videos related to

Pageof 67
Sort By:
Shock (Augusta, Ga.)|May 7, 2024
TRANSCRIPTOMIC DIFFERENCES IN PERIPHERAL MONOCYTE POPULATIONS IN SEPTIC PATIENTS BASED ON OUTCOMEEvan L Barrios, Jaimar C Rincon, Micah Willis, et al.
British Journal of Haematology|September 21, 2022
Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemiaRoma V Rajput, Xiaoyang Ma, Kristin L Boswell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2020
Transcriptomic responses from improved murine sepsis models can better mimic human surgical sepsisPhilip A Efron, Dijoia B Darden, Zhongkai Wang, et al.
Frontiers in Immunology|December 18, 2024
Unique lymphocyte transcriptomic profiles in septic patients with chronic critical illnessEvan L Barrios, Leandro Balzano-Nogueira, Valerie E Polcz, et al.
Frontiers in Immunology|May 9, 2024
The post-septic peripheral myeloid compartment reveals unexpected diversity in myeloid-derived suppressor cellsEvan L Barrios, Jack R Leary, Dijoia B Darden, et al.
The Lancet. Infectious Diseases|August 17, 2024
Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trialKayvon Modjarrad, Paul T Scott, Melanie McCauley, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national studyFaris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.
The Journal of Infectious Diseases|May 11, 2022
Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019Shilpa Hakre, Ines Lakhal-Naouar, David B King, et al.
The Lancet. Infectious Diseases|June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trialMichael A Koren, Leyi Lin, Kenneth H Eckels, et al.
Journal of Chemical Information and Modeling|July 29, 2025
Recent Developments in Amber Biomolecular SimulationsDavid A Case, David S Cerutti, Vinícius Wilian D Cruzeiro, et al.
Pageof 67

Showing results (641-650 of 661) with videos related to

Sort By:
Pageof 67
Shock (Augusta, Ga.)|May 7, 2024
TRANSCRIPTOMIC DIFFERENCES IN PERIPHERAL MONOCYTE POPULATIONS IN SEPTIC PATIENTS BASED ON OUTCOMEEvan L Barrios, Jaimar C Rincon, Micah Willis, et al.
British Journal of Haematology|September 21, 2022
Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemiaRoma V Rajput, Xiaoyang Ma, Kristin L Boswell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2020
Transcriptomic responses from improved murine sepsis models can better mimic human surgical sepsisPhilip A Efron, Dijoia B Darden, Zhongkai Wang, et al.
Frontiers in Immunology|December 18, 2024
Unique lymphocyte transcriptomic profiles in septic patients with chronic critical illnessEvan L Barrios, Leandro Balzano-Nogueira, Valerie E Polcz, et al.
Frontiers in Immunology|May 9, 2024
The post-septic peripheral myeloid compartment reveals unexpected diversity in myeloid-derived suppressor cellsEvan L Barrios, Jack R Leary, Dijoia B Darden, et al.
The Lancet. Infectious Diseases|August 17, 2024
Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trialKayvon Modjarrad, Paul T Scott, Melanie McCauley, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national studyFaris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.
The Journal of Infectious Diseases|May 11, 2022
Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019Shilpa Hakre, Ines Lakhal-Naouar, David B King, et al.
The Lancet. Infectious Diseases|June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trialMichael A Koren, Leyi Lin, Kenneth H Eckels, et al.
Journal of Chemical Information and Modeling|July 29, 2025
Recent Developments in Amber Biomolecular SimulationsDavid A Case, David S Cerutti, Vinícius Wilian D Cruzeiro, et al.
Pageof 67